Literature DB >> 10671788

Comparative study of two different TRUS-guided sextant biopsy techniques in detecting prostate cancer in one biopsy session.

C Brössner1, S Madersbacher, G Bayer, A Pycha, H C Klingler, U Maier.   

Abstract

OBJECTIVE: The aim of this study was to compare a transrectal ultrasound (TRUS)-guided sextant biopsy technique, which puts more emphasis on the apical region of the prostate where most prostate carcinomas (PCs) develop, with the standard sextant biopsy technique.
METHODS: A total of 280 patients with suspected PC were included in this analysis. Twelve biopsy cores were obtained from all patients. Six biopsy cores were taken within a lateral parasagittal plane from each lobe at the apex, middle and basis, with an angle of approximately 45 degrees (technique A), and 6 further biopsy cores were taken from the left to the right lateral margin always penetrating the prostate in the apex with the same angle (socalled fan-shaped technique, technique B). Technique A predominantly samples in the sagittal and technique B samples more in the transversal plane with emphasis on the apical region where most PCs develop. The sensitivity in detecting PCs for both techniques was calculated and correlated to the serum prostate-specific antigen (PSA) levels.
RESULTS: A total of 72 PCs (25.7%) were diagnosed. We subsequently performed subgroup analysis depending on the serum PSA levels: in patients with a PSA of </=10 ng/ml (n = 27) technique A has a PC sensitivity of 88.8% (p = 0.037) and technique B 96.2% (p = 0.326) as compared to our reference standard of 100% by sampling 12 biopsy cores in the same prostate. The number of positive biopsy cores using technique B was superior in 12 cases as compared to 3 cases with technique A (p = 0.04). In 12 patients the number of positive biopsy cores was identically. In patients with a PSA of >10 ng/ml (n = 45) technique A has a PC sensitivity of 93.3% (p = 0.083) and technique B 88.8% (p = 0.023) as compared to our reference standard. The number of positive core biopsies using technique A was superior in 14 cases as compared to 12 with technique B (p = 0.154). In 19 patients the number of positive biopsies was identical.
CONCLUSION: Our data suggest that in patients with PSA of </=10 ng/ml technique B bring significant benefit with regard to the number of positive core biopsies, as well as an enhanced PC detection rate which is near the 12-core biopsy. Due to the fact that technique B samples more in the apical region where most cancers develop, it should be performed in suspected early stage cancers of the prostate (PSA</=10 ng/ml).

Entities:  

Mesh:

Year:  2000        PMID: 10671788     DOI: 10.1159/000020102

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

1.  Follow-up of men obtaining a six-core versus a ten-core benign prostate biopsy 7 years previously.

Authors:  Clemens Brossner; Stefan Madersbacher; Phillip de Mare; Anton Ponholzer; Bader Al-Ali; Michael Rauchenwald
Journal:  World J Urol       Date:  2005-12-03       Impact factor: 4.226

2.  Distribution of prostate carcinoma foci within the peripheral zone: analysis of 8,062 prostate biopsy cores.

Authors:  C Brossner; A Winterholer; M Roehlich; E Dlouhy-Schütz; V Serra; M Sonnleithner; K H Grubmüller; K Pummer; E Schuster
Journal:  World J Urol       Date:  2003-06-03       Impact factor: 4.226

Review 3.  How to improve prostate biopsy detection of prostate cancer.

Authors:  D K Ornstein; J Kang
Journal:  Curr Urol Rep       Date:  2001-06       Impact factor: 3.092

4.  Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases.

Authors:  Lauro S Gomez-Guerra; Margarita L Martinez-Fierro; Valeria Alcantara-Aragon; Rocio Ortiz-Lopez; Rebeca T Martinez-Villarreal; Idelma B Morales-Rodriguez; Raquel Garza-Guajardo; Marco A Ponce-Camacho; Augusto Rojas-Martinez
Journal:  BMC Cancer       Date:  2009-03-24       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.